泰格医药
港股通 官网
( 03347.hk)
市盈率25.10市净率1.20市销率3.64股息率1.92%上市时间2020-08-07股价32.35港币 (-4.85% , 6,403.71万港币) 市值279.81亿港币总股本8.65亿上市至今年化投资收益率-24.36%港股通持仓占H股比例45.58%累计做空占H股本比8.22%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
所属指数指数纳入纳出
同股同权查看历史折扣
备注 (0): 双击编辑备注
发表讨论

泰格医药(03347) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1聞增玉Executive Director2023-05-23--
2袁華剛Independent Non Executive Director2023-05-23--
3吳灝Executive Director2021-10-15--
4廖啟宇Independent Non Executive Director - A/F2020-04-01--
5楊波Independent Non Executive Director2020-04-01--
6鄭碧筠Independent Non Executive Director2017-06-012023-05-23
7曹曉春Executive Director2010-09-01--
8葉小平Executive DirectorChairman2010-09-01--
9YIN ZhuanExecutive Director2010-09-012023-05-23